Molecular structure of O-Desmethyl Astemizole, CAS Number: 73736-50-2
O-Desmethyl Astemizole (CAS 73736-50-2)
See product citations (1)
Alternate Names:
4-[2-[4-[[1-[(4-Fluorophenyl)methyl]-1H-benzimidazol-2-yl]amino]-1-piperidinyl]ethyl]phenol; O-Demethylastemizole
Application:
O-Desmethyl Astemizole is an Astemizole metabolite (Order -CW for certified weight, analytical data, etc.)
CAS Number:
73736-50-2
Purity:
98%
Molecular Weight:
444.54
Molecular Formula:
C27H29FN4O
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Product Citations
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
O-Desmethyl Astemizole is a metabolite of astemizole. It is formed through the process of demethylation, which involves the removal of a methyl group from the parent compound. O-Desmethyl Astemizole retains some of the pharmacological properties of astemizole, including its ability to block the H1 histamine receptor. O-Desmethyl Astemizole is also known to have a longer half-life than astemizole. O-Desmethyl Astemizole is an important compound to consider in the astemizole metabolism.
O-Desmethyl Astemizole (CAS 73736-50-2) References
- Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity. | Lee, CA., et al. 2012. Drug Metab Dispos. 40: 943-51. PMID: 22328583
- Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors. | Ren, S., et al. 2013. Drug Metab Dispos. 41: 60-71. PMID: 23033255
- Potential of decursin to inhibit the human cytochrome P450 2J2 isoform. | Lee, B., et al. 2014. Food Chem Toxicol. 70: 94-9. PMID: 24788058
- Characterization of the active site properties of CYP4F12. | Eksterowicz, J., et al. 2014. Drug Metab Dispos. 42: 1698-707. PMID: 25074871
- Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner. | Lee, E., et al. 2015. Drug Metab Dispos. 43: 1250-3. PMID: 26048912
- Repurposing Cationic Amphiphilic Antihistamines for Cancer Treatment. | Ellegaard, AM., et al. 2016. EBioMedicine. 9: 130-139. PMID: 27333030
- Inhibitory Effect of Selaginellins from Selaginella tamariscina (Beauv.) Spring against Cytochrome P450 and Uridine 5'-Diphosphoglucuronosyltransferase Isoforms on Human Liver Microsomes. | Heo, JK., et al. 2017. Molecules. 22: PMID: 28934153
- Terfenadone is a strong inhibitor of CYP2J2 present in the human liver and intestinal microsomes. | Lee, E., et al. 2018. Drug Metab Pharmacokinet. 33: 159-163. PMID: 29759885
- Generation and Characterization of Cytochrome P450 2J3/10 CRISPR/Cas9 Knockout Rat Model. | Lu, J., et al. 2020. Drug Metab Dispos. 48: 1129-1136. PMID: 32878767
- Development and characterization of rat duodenal organoids for ADME and toxicology applications. | Hedrich, WD., et al. 2020. Toxicology. 446: 152614. PMID: 33199268
- Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors. | Leow, JWH., et al. 2021. Eur J Pharm Sci. 164: 105889. PMID: 34044117
- Hypercholesterolemia reduces the expression and function of hepatic drug metabolizing enzymes and transporters in rats. | Xu, Y., et al. 2022. Toxicol Lett. 364: 1-11. PMID: 35654319
- New Insights into Ion Channels: Predicting hERG-Drug Interactions. | Wempe, MF. 2022. Int J Mol Sci. 23: PMID: 36142644
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
O-Desmethyl Astemizole, 1 mg | sc-215605 | 1 mg | $326.00 | |||
O-Desmethyl Astemizole, 1 mg | sc-215605-CW | 1 mg | $480.00 |